TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
Tvingsholm SA, Frej MS, Rafa VM, Hansen UK, Ormhøj M, Tyron A, Jensen AWP, Kadivar M, Bentzen AK, Munk KK, Aasbjerg GN, Ternander JSH, Heeke C, Tamhane T, Schmess C, Funt SA, Kjeldsen JW, Kverneland AH, Met Ö, Draghi A, Jakobsen SN, Donia M, Marie Svane I, Hadrup SR.
Tvingsholm SA, et al. Among authors: hansen uk.
J Immunother Cancer. 2023 Aug;11(8):e006847. doi: 10.1136/jitc-2023-006847.
J Immunother Cancer. 2023.
PMID: 37586765
Free PMC article.